title: Reanalysis of TransVax immunogenicity.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Kharfan-Dabaja
authors.forename: Michael
authors.initials: M
authors.lastname: Boeckh
authors.forename: Marissa B
authors.initials: MB
authors.lastname: Wilck
authors.forename: Amelia A
authors.initials: AA
authors.lastname: Langston
authors.forename: Alice H
authors.initials: AH
authors.lastname: Chu
authors.forename: Mary K
authors.initials: MK
authors.lastname: Wloch
authors.forename: Larry R
authors.initials: LR
authors.lastname: Smith
authors.forename: Alain P
authors.initials: AP
authors.lastname: Rolland
authors.forename: Richard T
authors.initials: RT
authors.lastname: Kenney
mesh_terms: D000917:Antibody Formation; D017322:Clinical Trials, Phase II as Topic; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000276:immunology*; D006801:Humans; D019444:Vaccines, DNA / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D019444:Vaccines, DNA; D014765:Viral Vaccines